Skip to main content

Physician Search

 


Displaying 1 - 1 of 1

Study of BMF-219, in Adult Patients With Acute Leukemia, Diffuse Large B-Cell Lymphoma and Multiple Myeloma

Multiple Cancer Types

A Phase1 first-in-human dose-escalation and dose-expansion study of BMF-219, an oral irreversible menin inhibitor, in adult patients with acute leukemia, diffuse large B-cell lymphoma, and multiple myeloma
Leukemia, Phase I
I
Kishtagari, Ashwin
NCT05153330
VICCHEMP2195